HUNTSVILLE, Ala., Nov. 14, 2011 /PRNewswire/ -- Qualitest Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL.
The total sales for Acetaminophen and Codeine Phosphate Oral Solution in the U.S. for the 12 months ended September 30, 2011 were approximately $4.3 million, according to IMS Health.
About Qualitest
Founded in 1983, Qualitest provides affordable, high-quality generic pharmaceuticals. Featuring a current portfolio exceeding 600 products, the company has grown significantly since its inception and is now ranked in the top ten among all suppliers of generics, based on total prescriptions filled. Qualitest is a wholly owned subsidiary of Endo Pharmaceuticals (Nasdaq: ENDP), a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics (www.endo.com).
SOURCE Endo Pharmaceuticals
